Skip to main content
. 2023 Jan 16;10:1037157. doi: 10.3389/fpubh.2022.1037157

Figure 3.

Figure 3

Estimated MR PDR delivered by MAPs and N/S for countries using MR in their national immunization schedules, between 2030 and 2040. MR, measles rubella; PDR, programmatic doses required; MAPs, microarray patches; and N/S, needle and syringe.